Jefferies Group LLC Incyte Corp Put Options Transaction History

Jefferies Group LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Sep 21, 2023	BUY	$80.74 - $97.7 $1.92 Million - $2.33 Million	23,800 New	23,800 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $597,476 - $722,980	7,400 Added 45.12%	23,800 $2.07 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $5.17 Million - $7.59 Million	-69,700 Reduced 80.95%	16,400 $1.71 Million
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $4.49 Million - $6.1 Million	71,000 Added 470.2%	86,100 $6.31 Million
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $270,248 - $354,164	3,700 Added 32.46%	15,100 $1.32 Million
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $822,865 - $977,676	11,300 Added 11300.0%	11,400 $846,000
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $1.46 Million - $1.77 Million	-19,900 Reduced 99.5%	100 $8,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $635,600 - $881,700	10,000 Added 100.0%	20,000 $1.72 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $608,500 - $839,800	10,000 New	10,000 $670,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.